Liquidia (LQDA) EBITDA Margin (QoQ) (2021 - 2026)
Liquidia (LQDA) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,479.00 |
| Dec 31, 2025 | 1,825.00 |
| Sep 30, 2025 | 42,766.00 |
| Jun 30, 2025 | 71,101.00 |
| Mar 31, 2025 | 10,240.00 |
| Dec 31, 2024 | -58,159.00 |
| Sep 30, 2024 | 8,706.00 |
| Jun 30, 2024 | 22,579.00 |
| Mar 31, 2024 | -38,563.00 |
| Dec 31, 2023 | -17,858.00 |
| Sep 30, 2023 | 7,205.00 |
| Jun 30, 2023 | -27,144.00 |
| Mar 31, 2023 | -8,426.00 |
| Dec 31, 2022 | 15,781.00 |
| Sep 30, 2022 | -5,008.00 |
| Jun 30, 2022 | 18,549.00 |
| Mar 31, 2022 | -6,103.00 |
| Dec 31, 2021 | -12,438.00 |
| Sep 30, 2021 | -3,497.00 |
| Jun 30, 2021 | 9,780.00 |